ReNeuron Group Company
Stroke oriented, stem cell therapies. Primary objective is the development of novel stem cell therapies targeting areas of significant unmet or poorly met medical need.
.png)
.png)
Technology:
AgeTech Companies
Industry:
Healthcare
Headquarters:
United Kingdom
Founded Date:
01.01.1997
Employees Number:
51-100
Funding Status:
IPO
Acquisitions Number:
1
Investors Number:
4
Total Funding:
167 333 065
Estimated Revenue:
$1M to $10M
Last Funding Date:
10.07.2015
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership